Paul Colvin

Chief Business Officer
  • Responsible for driving the growth strategy for Syneos Health, fueled by a proactive Go to Market ecosystem
  • Leads the company’s Customer Engagement and Business/Market Development portfolio across the enterprise; Leverages the corporate strategy to create and institutionalize innovative solutions for customers and ensures the voice of the customer is at the center of Syneos Health across the product development and commercialization continuum
  • Previously served as President, Clinical Solutions at Syneos Health, driving deep customer relationships [and or customer network/roster] and establishing a product development mindset to accelerate deployment of high-value solutions to the marketplace
  • Three decades of experience in global clinical development in the CRO and biopharmaceutical industries including serving as Executive Vice President, Biopharma Partnerships and Chairman and CEO of PPD-SNBL, a joint venture that has grown to be one of the largest clinical development service providers in Japan
  • Spent nearly 15 years at Eli Lilly and Company in a variety of increasingly significant roles gaining global, operational and patient enrollment experience across multiple therapeutic areas
  • Bachelor of Science in Pharmacy, Butler University; Registered Pharmacist; Completed executive development programs at London Business School and the Center for Creative Leadership